Fate Therapeutics
FATE
#9137
Rank
A$0.13 B
Marketcap
$1.18
Share price
5.26%
Change (1 day)
-88.90%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$3.27

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.59. In 2022 the company made an earnings per share (EPS) of -$4.82 a decrease over its 2021 EPS that were of -$3.69.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.27-32.08%
2022-$4.8230.49%
2021-$3.697.21%
2020-$3.4445.45%
2019-$2.3719.17%
2018-$1.9917.65%
2017-$1.69-3.77%
2016-$1.75-12.4%
2015-$2.00-3.97%
2014-$2.09-2.09%
2013-$2.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$12.96 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.19-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$14.32 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.13 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.24-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA